A Letter from our President

Although the DSCSA deadline has been extended, Camber has been ready for over a year. You can read more about it in a recent letter from Camber’s president to our customers. You can learn more about how Camber has prepared at our DSCSA Compliance Page.
Recent articles
- Camber Launches Temozolomide Capsules, USP
- Camber Launches Eltrombopag Tablets & Oral Suspension
- Camber Launches Eslicarbazepine Acetate Tablets
- Camber Launches Phenylephrine Hydrochloride Injection, USP
- Camber Launches Chlorzoxazone Tablets, USP
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year